Atezolizumab
Showing 551 - 575 of 765
Solid Tumors Trial in Worldwide (Atezolizumab, Cergutuzumab Amunaleukin)
Completed
- Solid Tumors
- Atezolizumab
- Cergutuzumab Amunaleukin
-
New Haven, Connecticut
- +13 more
Jan 15, 2020
DLBCL, Not Otherwise Specified Trial in Amsterdam, Groningen (89Zr-atezolizumab PET scans)
Recruiting
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- 89Zr-atezolizumab PET scans
-
Amsterdam, Noord-Holland, Netherlands
- +1 more
Jun 14, 2019
Lung Cancer Trial in Shanghai (chemo plus TCM 1&ICIs plusTCM2 , chemo plus TCM 1 &ICIs plus TCM2 )
Not yet recruiting
- Lung Cancer
- chemotherapy plus TCM 1&ICIs plusTCM2 placebo
- chemotherapy plus TCM 1placebo &ICIs plus TCM2 placebo
-
Shanghai, Shanghai, ChinaYueYang Hosptial of Intergrated Traditional Chinese and Western
Apr 17, 2023
Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma Trial in Canada,
Recruiting
- Breast Adenocarcinoma
- +8 more
- Atezolizumab
- +6 more
-
Birmingham, Alabama
- +667 more
Apr 6, 2022
NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in Lexington (Immune checkpoint inhibitor, Radiation Therapy)
Recruiting
- Non-small Cell Lung Cancer
- Squamous Cell Carcinoma of the Head and Neck
- Immune checkpoint inhibitor
- Radiation Therapy
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Nov 10, 2022
Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)
Recruiting
- Advanced Unresectable or Metastatic Solid Malignancy
- Entrectinib
- +11 more
-
Birmingham, Alabama
- +50 more
Aug 10, 2022
Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)
Recruiting
- Non-small Cell Lung Cancer
- Extensive Disease Small Cell Lung Cancer
-
Akashi, Japan
- +147 more
Jun 23, 2021
NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
- GDC-6036
- +6 more
-
Duarte, California
- +68 more
Jan 10, 2023
Liver Cancer Trial in Kansas City (Stereotactic Body Radiation Treatment)
Not yet recruiting
- Liver Cancer
- Stereotactic Body Radiation Treatment
-
Kansas City, KansasUniversity of Kansas Medical Center
Feb 13, 2023
Cancer of Unknown Primary Site Trial in Worldwide (Alectinib, Vismodegib, Ipatasertib)
Active, not recruiting
- Cancer of Unknown Primary Site
- Alectinib
- +17 more
-
Blacktown, New South Wales, Australia
- +140 more
Jan 6, 2023
Polish Microbiome Map
Unknown status
- Melanoma
- +4 more
- Collection of stool samples
-
Poznań, PolandThe Institute of Bioorganic Chemistry, Polish Academy of Science
Nov 19, 2019
Castrate-Resistant Prostate Cancer Trial in United States (Atezolizumab, Radium-223 Dichloride)
Completed
- Castrate-Resistant Prostate Cancer
- Atezolizumab
- Radium-223 Dichloride
-
Duarte, California
- +16 more
Sep 23, 2019
Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)
Recruiting
- Advanced Solid Tumors
- Kirsten Rat Sarcoma (KRAS) pG12C Mutation
- Sotorasib
- +15 more
-
Tucson, Arizona
- +83 more
Dec 28, 2022
Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic Trial in Korea, Republic
Terminated
- Cholangiocarcinoma Non-resectable
- +3 more
- PEGPH20
- +3 more
-
Phoenix, Arizona
- +35 more
Jan 24, 2020
Rectal Cancer Stage, Oesophageal Cancer Trial in Vienna (CRT, SCPRT, CROSS Protocol)
Not yet recruiting
- Rectal Cancer Stage
- Oesophageal Cancer
- CRT
- +3 more
-
Vienna, AustriaMedical University of Vienna
Mar 26, 2022
MDS Trial in United States (Atezolizumab, Azacitidine)
Completed
- Myelodysplastic Syndromes
- Atezolizumab
- Azacitidine
-
Duarte, California
- +14 more
Aug 15, 2019